Birkenstock (NYSE:BIRK) Stock Moved Down to “Strong Sell” by Williams Trading

Birkenstock (NYSE:BIRK) was downgraded by equities research analysts at Williams Trading from a “hold” rating to a “strong sell” rating in a research note issued on Friday, Zacks reports.

BIRK has been the subject of several other research reports. JPMorgan Chase & Co. increased their target price on shares of Birkenstock from $49.00 to $58.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 4th. BMO Capital Markets began coverage on Birkenstock in a research report on Tuesday, September 8th. They issued a “market perform” rating and a $35.00 price target on the stock. Seaport Research Partners downgraded Birkenstock from a “buy” rating to a “neutral” rating in a research note on Monday, July 20th. Telsey Advisory Group increased their price objective on Birkenstock from $45.00 to $50.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Finally, Weiss Ratings cut Birkenstock from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, September 22nd. Thirteen research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Birkenstock presently has an average rating of “Moderate Buy” and an average price target of $51.91.

Birkenstock Stock Performance

NYSE:BIRK traded down $2.01 during trading hours on Friday, reaching $33.88. 2,730,305 shares of the company’s stock were exchanged, compared to its average volume of 1,799,029. Birkenstock has a 1-year low of $29.93 and a 1-year high of $50.73. The company has a quick ratio of 2.09, a current ratio of 3.78 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $6.03 billion, a price-to-earnings ratio of 15.87, a P/E/G ratio of 1.18 and a beta of 1.30. The company has a 50-day moving average of $34.03 and a 200 day moving average of $38.53.

Birkenstock (NYSE:BIRK) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.86 EPS for the quarter, missing analysts’ consensus estimates of $0.88 by ($0.02). The business had revenue of $834.65 million during the quarter, compared to analyst estimates of $827.39 million. Birkenstock had a net margin of 14.82% and a return on equity of 13.36%. The company’s revenue for the quarter was up 13.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.62 earnings per share. Birkenstock has set its FY 2026 guidance at 2.220-2.400 EPS. Research analysts anticipate that Birkenstock will post 2.20 EPS for the current year.

Institutional Trading of Birkenstock

Several hedge funds have recently made changes to their positions in BIRK. Vontobel Holding Ltd. purchased a new stake in shares of Birkenstock in the third quarter valued at approximately $905,000. Mather Group LLC. purchased a new stake in Birkenstock in the 3rd quarter valued at approximately $27,000. WINTON GROUP Ltd purchased a new stake in shares of Birkenstock in the second quarter valued at $417,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Birkenstock during the 2nd quarter worth about $34,000. Finally, Squarepoint Ops LLC boosted its position in Birkenstock by 438.0% during the second quarter. Squarepoint Ops LLC now owns 99,537 shares of the company’s stock worth $4,283,000 after acquiring an additional 81,037 shares during the last quarter. Institutional investors and hedge funds own 19.93% of the company’s stock.

About Birkenstock

Birkenstock is a global footwear company best known for its contoured cork-latex footbed, which is designed to support the natural shape of the foot. The company offers sandals, shoes, clogs, boots and other footwear, along with accessories and foot-care products. Its portfolio includes classic styles such as Arizona, Boston, Madrid and Gizeh.

Birkenstock traces its roots to 1774, when Johann Adam Birkenstock was recorded as a shoemaker in Germany. The company’s modern footbed concept was developed in the late 19th and early 20th centuries, helping establish its reputation for comfort, functionality and orthopedic-inspired design.